Skip to main content
. 2021 Jun 17;62:100092. doi: 10.1016/j.jlr.2021.100092

Fig. 8.

Fig. 8

Effect of shark liver oil supplementation on white blood cell lipids. Estimated effects of shark liver oil (SLO) supplementation on (log-transformed) circulatory white blood cell lipid concentrations (normalized to phosphatidylcholine concentration) relative to placebo treatments. Open gray circles: lipid species, nonsignificant, no confidence intervals (CIs); violet circles: lipid species, nominally significant (P < 0.05), with CIs; blue circles: lipid species, significant after multiple testing correction (P < 0.05) using Benjamini-Hochberg’s approach, with CIs; red diamonds: lipid class/subclass totals, significant after multiple testing correction (P < 0.05) using Benjamini-Hochberg’s approach, with CIs. Cer, ceramide; COH, cholesterol; CdhCer, dihydroceramide; DG, diacylglycerol; E, cholesteryl ester; HexCer, monohexosylceramide; Hex2Cer, dihexosylceramide; Hex3Cer, trihexosylceramide; GM3, GM3 ganglioside; PC(O), alkyl phosphatidylcholine; PC(P), alkenyl phosphatidylcholine; LPC, lysophosphatidylcholine; LPC(O), lysoalkylphosphatidylcholine; LPE, lysophosphatidylethanolamine; LPI, lysophosphatidylinositol; PE, phosphatidylethanolamine; PE(O), alkyl phosphatidylethanolamine; PE(P), alkenyl phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin; TG, triacylglycerol.